Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy Article Report uri icon

Overview

MeSH Major

  • Cornea
  • Microscopy, Confocal
  • Nerve Fibers
  • Peripheral Nervous System Diseases

abstract

  • A large number of measures may be employed in clinical practice and for epidemiologic studies to quantify and risk stratify diabetic patients with neuropathy. However, not all measures are suitable for assessing the benefits of therapeutic intervention. Therefore, for the purpose of this review we focus on measures that may be employed to define the efficacy of interventions in clinical trials of human diabetic neuropathy. Two major types of end points are used: 1) those that assess symptoms for defining efficacy in painful diabetic neuropathy, and 2) those that assess neurologic deficits that assess the effects of treatments that may prevent further degeneration or promote repair.

publication date

  • December 2005

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1007/s11892-005-0048-6

PubMed ID

  • 16316591

Additional Document Info

start page

  • 417

end page

  • 22

volume

  • 5

number

  • 6